On February 20, ADVI Health’s vice president, strategic analytics, value and economics (SAVEs), Peter Kardel, MPsych, was included in Specialty Pharmacy Continuum’s article, Pharmacists Combat Rising Hepatitis C Rates, sharing insight on the rate of CRS occurrence in CAR-T therapy clinical trials.

In the article, he expands on CAR-T cases covered in Medicare, revealing that the rate of CRS was significantly lower for beneficiaries receiving CAR-T as outpatients compared to the inpatient setting. This was found from ADVI’s assessment, analyzing 2,733 CAR-T cases covered by Medicare from the third quarter of 2020 through the fourth quarter of 2022.

Read more of Peter’s insights in Specialty Pharmacy Continuum.